Study reverses course on Gulf War illnesses
Panel recommends spending $60 million on more studies
WASHINGTON (AP) -- Parting company
with the findings of a Clinton administration panel on Gulf War
illnesses, a new study concludes more must be learned about the
effects of toxic substances on those who fought there.
The Research Advisory Committee on Gulf War Illness urges that up
to $60 million be spent over the next four years to monitor and
research the health of Gulf War veterans and their children.
In so doing, the panel distanced itself from the earlier body
that attributed a series of mysterious ailments to stress under
conditions of warfare. Scientists are coming close to finding a
treatment, the panel said in its report, but it also said
researchers need substantially more government financial
assistance.
The Associated Press obtained a copy of the report in advance of
its expected release Friday by Veterans Affairs Secretary Anthony
Principi.
The review committee that Principi formed concluded that "the
goal of understanding and treating Gulf War veterans' illnesses is
within reach" because of recent research breakthroughs.
But federal research is falling short in large part because
studies have not asked important questions and continue to focus on
stress to explain the veterans' problems.
"Additional progress in addressing Gulf War veterans' illnesses
is not likely to come from a haphazard mix of studies," the panel
said.
Department officials declined comment before the review was made
public.
Hundreds of thousands of veterans of the 1991 Gulf War have
experienced undiagnosed illnesses they believe are linked to the
war, according to Congress' auditing arm. These ailments include
chronic fatigue, loss of muscle control, diarrhea, migraines,
dizziness, memory problems and loss of balance.
Principi's panel found that more recent studies suggest the
veterans' illnesses are neurological and apparently are linked to
exposure to neurotoxins such as the nerve gas sarin, the anti-nerve
gas drug pyridostigmine bromide and pesticides that affect the
nervous system.
"Research studies conducted since the war have consistently
indicated that psychiatric illness, combat experience or other
deployment-related stressors do not explain Gulf War veterans
illnesses in the large majority of ill veterans," the review
committee said.
The Pentagon has estimated that about 100,000 soldiers were
exposed to nerve gas when Iraqi weapons caches were destroyed,
although congressional auditors have questioned the Defense
Department's estimates. The Pentagon also has said some soldiers may
have been overexposed to pesticides.
The committee said the VA should allocate $15 million in each of
the next four years for a Gulf War illness research program.
Principi had announced in 2002 that $20 million would be
available for research this year. But during the summer, the panel
found that little of that had been spent and some of what was went
to studies investigating stress-related causes.
Recent research "makes it a very reasonable possibility that this
Gulf War illness is not attributable simply to stress of troops that
were deployed," said Paul Greengard, who won the Nobel Prize for
work discovering the brain mechanisms involved in Parkinson's
disease, a nerve disorder.
Greengard is the founder of Intracellular Therapies, which looks
for treatments for central nervous system disorders. He said the
company recently began investigating how nerve agents damage the
brain.
Greengard has done preliminary work funded by the Army that would
apply the research methods he used to investigate Parkinson's to
study Gulf War illnesses.
"I think any reasonable person can no longer exclude the
possibility that our military personnel deployed in Gulf War I were
exposed to toxic chemicals that have produced this very high
incidence of illnesses," Greengard said.
Copyright 2004 The Associated
Press. |